Articles

PP20 Cost-effectiveness of Ibrutinib as Frontline Treatment For Adult Patients With Chronic Lymphocytic Leukaemia in Belgium

BJH - 2018, issue Abstract Book BHS, february 2018

A. Smet , S. Peng , E. Dorman , K. Deger , S. Sorensen , S. Baculea , S. Cote

Read more

P33 Use of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice: Results from the Belgian Ibrutinib Real-World Data (BiRD) Study

BJH - 2018, issue Abstract Book BHS, february 2018

A. Janssens MD, PhD, S. Snauwaert MD, PhD, R. Wapenaar , C. Van Bogaert , A. Smet , V. Seynhaeve

Read more

P15 Treatment patterns of Waldenström’s macroglobulinemia in Belgium

BJH - volume 8, issue Abstract Book BHS, february 2017

A. Smet , V. Van Hende MD, M. André MD, PhD, C. Bonnet MD, PhD, G. Bries MD, PhD, V. De Wilde MD, PhD, H. Demuynck MD, N. Meuleman MD, PhD, W. Schroyens MD, PhD, A. Van Hoof MD, PhD, M. Giordan , L. de Vos , A. Janssens MD, PhD

Read more
X